STOCKHOLDERS' DEFICIT (Details Textual) (USD $)
|
3 Months Ended | 12 Months Ended | 24 Months Ended | 12 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 6 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 3 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 12 Months Ended | 6 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 6 Months Ended | 1 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2014
|
Dec. 31, 2013
|
Mar. 26, 2013
|
Dec. 31, 2012
|
Jan. 14, 2013
|
Sep. 30, 2013
|
Sep. 30, 2012
|
Sep. 30, 2013
|
Nov. 08, 2013
|
Mar. 31, 2013
|
Sep. 30, 2013
Ten Vendors [Member]
|
Sep. 30, 2012
Before Amendment [Member]
|
Sep. 30, 2012
After Amendment [Member]
|
Sep. 30, 2013
$1 Notes [Member]
|
Sep. 30, 2012
October 2012 Note [Member]
|
Nov. 30, 2012
October 2012 Note [Member]
|
Mar. 26, 2013
Private Placement [Member]
|
Sep. 30, 2013
Forfeiture and Exchange Agreements [Member]
|
Sep. 30, 2012
Forfeiture and Exchange Agreements [Member]
|
Mar. 31, 2014
Plan 2012 [Member]
|
Mar. 22, 2012
Plan 2012 [Member]
|
Mar. 31, 2010
Plan 2006 [Member]
|
Sep. 30, 2011
Plan 2006 [Member]
|
Sep. 30, 2006
Plan 2006 [Member]
|
Aug. 03, 2006
Plan 2006 [Member]
|
Mar. 31, 2013
Amendment Plan 2012 [Member]
|
Mar. 31, 2014
Amendment Plan 2006 [Member]
|
Dec. 31, 2013
2012 Omnibus Incentive Compensation Plan [Member]
|
Mar. 31, 2013
Common Stock [Member]
|
Dec. 31, 2013
Minimum [Member]
|
Mar. 26, 2013
Minimum [Member]
|
Dec. 31, 2012
Minimum [Member]
|
Jan. 14, 2013
Minimum [Member]
|
Mar. 31, 2014
Minimum [Member]
|
Dec. 31, 2012
Minimum [Member]
Plan 2012 [Member]
|
Mar. 26, 2013
Minimum [Member]
Amendment Plan 2012 [Member]
|
Dec. 31, 2013
Maximum [Member]
|
Mar. 26, 2013
Maximum [Member]
|
Dec. 31, 2012
Maximum [Member]
|
Jan. 14, 2013
Maximum [Member]
|
Mar. 31, 2014
Maximum [Member]
|
Dec. 31, 2012
Maximum [Member]
Plan 2012 [Member]
|
Mar. 26, 2013
Maximum [Member]
Amendment Plan 2012 [Member]
|
Mar. 31, 2014
Monarch Capital Group Llc [Member]
|
Dec. 31, 2013
Monarch Capital Group Llc [Member]
|
Sep. 30, 2013
Monarch Capital Group Llc [Member]
|
Sep. 30, 2013
Monarch Capital Group Llc [Member]
October 2012 Note [Member]
|
Sep. 30, 2013
Mr. Tony Pullen [Member]
October 2012 Note [Member]
|
Dec. 31, 2012
Accredited Third Party Investor [Member]
October 2012 Note [Member]
|
Mar. 26, 2013
Accredited Third Party Investor [Member]
Private Placement [Member]
|
Sep. 30, 2013
Nineteen Accredited Investors [Member]
Private Placement [Member]
|
Sep. 30, 2013
Key Consultants [Member]
|
Sep. 30, 2012
Blu Mont Capital Corp [Member]
|
Dec. 31, 2013
Accredited Investor [Member]
|
Sep. 30, 2013
Twenty Three Accredited Investors [Member]
Private Placement [Member]
|
Mar. 31, 2014
D&D Securities Inc [Member]
|
Sep. 30, 2013
SAIL Capital Partners [Member]
Senior Notes [Member]
|
Mar. 31, 2014
Twenty Nine Accredited Investors [Member]
Private Placement [Member]
|
Mar. 22, 2012
Director One [Member]
|
Mar. 22, 2012
Director Two [Member]
|
Dec. 31, 2013
George Carpenter [Member]
|
Sep. 30, 2012
George Carpenter [Member]
Forfeiture and Exchange Agreements [Member]
|
Dec. 31, 2012
George Carpenter [Member]
Plan 2012 [Member]
|
Sep. 30, 2012
Michael Darkoch [Member]
Forfeiture and Exchange Agreements [Member]
|
Dec. 31, 2012
Michael Darkoch [Member]
Plan 2012 [Member]
|
Mar. 31, 2014
Three Existing and Four New Board [Member]
Plan 2012 [Member]
|
Dec. 31, 2012
Five Former Directors [Member]
Plan 2012 [Member]
|
Sep. 30, 2013
Staff [Member]
|
Dec. 31, 2013
Mr Paul Buck [Member]
|
Sep. 30, 2012
Mr Paul Buck [Member]
Forfeiture and Exchange Agreements [Member]
|
Dec. 31, 2012
Mr Paul Buck [Member]
Plan 2012 [Member]
|
Dec. 31, 2013
Stewart Navarre [Member]
|
Dec. 31, 2013
Brian MacDonald [Member]
|
Dec. 31, 2013
Two Creditors [Member]
Common Stock [Member]
|
Mar. 31, 2014
CNS California [Member]
|
Mar. 31, 2014
Colorado CNS Response [Member]
|
Mar. 31, 2014
Neuro-Therapy Clinic Inc [Member]
|
|
Stockholders' Equity Note [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 | 150,000,000 | 100,000,000 | 750,000,000 | 100,000,000 | 80,000,000 | 1,000,000 | 10,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock, shares authorized increased number (in shares) | 15,000,000 | 150,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock, shares issued (in shares) | 100,547,230 | 92,716,562 | 92,716,562 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock, shares outstanding (in shares) | 100,547,230 | 92,716,562 | 92,716,562 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock, shares authorized (in shares) | 15,000,000 | 20,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity, Reverse Stock Split | 1-for-30 reverse stock split | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Capital Shares Reserved for Future Issuance | 333,334 | 666,667 | 333,334 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee | 133,333 | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms | The option price for each share of stock subject to an option shall be (i) no less than the fair market value of a share of stock on the date the option is granted, if the option is an ISO, or (ii) no less than 85% of the fair market value of the stock on the date the option is granted, if the option is a NSO; provided, however, if the option is an ISO granted to an eligible employee who is a 10% shareholder, the option price for each share of stock subject to such ISO shall be no less than 110% of the fair market value of a share of stock on the date such ISO is granted. Stock options have a maximum term of ten years from the date of grant, except for ISOs granted to an eligible employee who is a 10% shareholder, in which case the maximum term is five years from the date of grant. ISOs may be granted only to eligible employees. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of Shares, Granted | 0 | 2,300,000 | 11,490,575 | 250,000 | 1,600,000 | 1,960,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | 42,670 | 439,689 | 8,334 | 8,334 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Exercise Price | $ 3.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance | 11,992,499 | 12,049,594 | 9,749,594 | 9,749,594 | 501,924 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 6,132 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit | $ 3.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit | $ 32.70 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants Outstanding Exercise Price | $ 0.04718 | $ 9.90 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized | $ 612,100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 3,509,425 | 87,786 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 11,273,100 | 11,275,000 | 7,723,300 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | 225,000 | 75,000 | 510,000 | 60,000 | 350,000 | 115,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Employee Compensation Amount Of Waiver | 56,250 | 43,333 | 66,083 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued In Consideration For Waiver | 56,250 | 43,333 | 66,083 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 333,334 | 5,500,000 | 5,500,000 | 15,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 1,200,000 | 920,000 | 250,000 | 25,000 | 1,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weighted Average Exercise Price, Granted | $ 0 | $ 0.25 | $ 0.25 | $ 0.25 | $ 0.04718 | $ 0.04718 | $ 0.04718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 36 months | 36 months | 36 months | 48 months | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 12.50% | 12.50% | 12.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Volume Of Shares Traded On Open Market | 180,000 | 283,400 | 15,000 | 36,700 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trading Days | 51 days | 22 days | 11 days | 21 days | 93 days | 58 days | 48 days | 50 days | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Per Share Value Of Shares Traded On Open Market | $ 0.30 | $ 0.46 | $ 0.76 | $ 0.49 | $ 1.74 | $ 0.83 | $ 0.83 | $ 2.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Convertible Notes Payable | 398,100 | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price | $ 1.00 | $ 0.25 | $ 0.25 | $ 0.25 | $ 1.00 | $ 0.04718 | $ 0.04718 | $ 0.04718 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock issued for purchase of common stock (in shares) | 2,780,000 | 4,180,000 | 8,000,000 | 5,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Issue Price Per Share | $ 0.001 | $ 0.25 | $ 0.25 | $ 0.25 | $ 0.25 | $ 0.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Private Placement | 2,500,000 | 695,000 | 1,045,000 | 2,047,500 | 2,000,000 | 1,475,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number Of Accredited Investors | 19 | 23 | 29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Stock Shares Authorized | 165,000,000 | 100,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued | 76,448,279 | 76,488,279 | 30,893,419 | 40,000 | 40,000 | 1,469,816 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value Issued For Lieu Of Cash To Creditors | 502,100 | 1,466,800 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares Issued For Lieu Of Cash To Creditors | 2,008,318 | 1,446,380 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion Original Debt Interest Amount | 1,661,000 | 1,661,100 | 1,359,400 | 50,000 | 219,800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument Convertible Conversion Price Before Amendment | $ 1.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument Convertible Conversion Price After Amendment | $ 0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion Original Debt Principal Amount | 9,612,100 | 9,613,900 | 6,363,900 | 1,900 | 1,250,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Options to purchase shares of common stock | 700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Exercise Price Per Share | $ 0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Extinguishment Of Salaries | 98,000 | 106,500 | 83,600 | 66,700 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Extinguishment Of Salaries Percentage | 50.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period | 0 | 0 | 70,825 | 435,000 | 470,000 | 385,000 | 310,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Single Financing Transaction Minimum Proceeds | $ 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indemnity Conversion Price Per Share Maximum Limit | $ 0.04718 |